Cite
MLA Citation
Yvette L. Kasamon et al.. “FDA Approval Summary: Selinexor for Relapsed or Refractory Diffuse Large B-Cell Lymphoma.” Oncologist, vol. 26, 2021, pp. 879–886. http://access.bl.uk/ark:/81055/vdc_100151233783.0x000020
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Yvette L. Kasamon et al.. “FDA Approval Summary: Selinexor for Relapsed or Refractory Diffuse Large B-Cell Lymphoma.” Oncologist, vol. 26, 2021, pp. 879–886. http://access.bl.uk/ark:/81055/vdc_100151233783.0x000020